CompletedInterventionalPhase 3Updated Nov 18, 2016
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension | NCT00293800 | Trialant
CompletedInterventionalPhase 3Updated Feb 14, 2012
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
ClinicalTrials.gov ID
NCT00293800
Lead Sponsor
Alcon ResearchINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 3
Enrollment
173Actual
Last Update Posted
Feb 14, 2012Estimated
Start Date
Jul 2004
Primary Completion Date
Dec 2005Actual
Completion Date
Dec 2005Actual
Brief Summary
The purpose of the study is to evaluate the safety and effectiveness of an investigational glaucoma therapy in patients with open-angle glaucoma or ocular hypertension.